Optimizing Treatment for Treatment-Experienced, HIV-Infected People

NCT00537394 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

517

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Enfuvirtide
DRUG: Raltegravir
DRUG: Darunavir
DRUG: Tipranavir
DRUG: Etravirine
DRUG: Maraviroc

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]